Anthem Biosciences Ltd
BSE: 544449
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 383.84-34.1% | 582.50+39.8% | 416.57-24.6% | 552.23+2.6% | 538.01 |
| Other Income | 28.60-52.8% | 60.63+51.9% | 39.92-25.8% | 53.80+94.0% | 27.73 |
| Total Income | 412.44-35.9% | 643.13+40.9% | 456.50-24.7% | 606.02+7.1% | 565.74 |
| EXPENSES | |||||
| Expenditure | 276.08-19.6% | 343.38+22.0% | 281.40-20.2% | 352.72-3.8% | 366.80 |
| Tax | 34.35-61.4% | 89.06+134.5% | 37.98-30.8% | 54.87+8.4% | 50.60 |
| PROFIT | |||||
| PBT | 136.36-54.7% | 300.72+100.3% | 150.11-40.7% | 253.30+27.3% | 198.94 |
| Net Profit | 102.01-51.8% | 211.66+88.8% | 112.12-43.5% | 198.43+33.8% | 148.34 |
| KEY METRICS | |||||
| OPM % | 34.08%-11.92pp | 46.00%+12.86pp | 33.14%-7.72pp | 40.86%+4.54pp | 36.32% |
| NPM % | 24.73%-8.18pp | 32.91%+8.35pp | 24.56%-8.18pp | 32.74%+6.52pp | 26.22% |
| EPS | 1.81-52.0% | 3.77+88.5% | 2.00-43.5% | 3.54+33.6% | 2.65 |
Corporate Events
Board MeetingANTHEM
202622Jul
Board Meeting
The 20th Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗